A COMPARISON OF BLOOD LIPID AND LIPOPROTEIN VALUES IN YOUNG-ADULTS WHO DIE SUDDENLY AND UNEXPECTEDLY FROM ATHEROSCLEROTIC CORONARY-ARTERY DISEASE WITH OTHER NONCARDIAC DEATHS
Jc. Hiserodt et al., A COMPARISON OF BLOOD LIPID AND LIPOPROTEIN VALUES IN YOUNG-ADULTS WHO DIE SUDDENLY AND UNEXPECTEDLY FROM ATHEROSCLEROTIC CORONARY-ARTERY DISEASE WITH OTHER NONCARDIAC DEATHS, The American journal of forensic medicine and pathology, 16(2), 1995, pp. 101-106
Postmortem blood lipid and lipoprotein analyses were conducted in a ca
se-controlled study of young adults (ages 22-43) who died suddenly and
unexpectedly of atherosclerotic coronary artery disease in Allegheny
County, Pennsylvania. None of the individuals in the study group (n =
28 cases) had a significant medical or cardiac history except in the i
mmediate antemortem period. The control group (n = 31) consisted of ag
e- and sex-matched cohorts who died of noncardiac related fatalities a
nd who had no evidence of CAD. The results indicated a male-to-female
ratio of nearly 30:1 with a marked predominance of young white men. Me
an total cholesterol (241 mg/dL), triglycerides (583 mg/dL), and low-d
ensity lipoproteins (LDL) (107 mg/dL) were all significantly elevated
in the study group as compared to controls (p<0.001, p<0.018, and p<0.
001 for the three parameters, respectively). Mean Apolipoprotein B (98
.7 mg/dL) was also significantly elevated compared to control values (
p<0.001). By contrast, mean high-density lipoprotein values (36 mg/dL)
were not significantly different from control values (p = 0.35), and
mean values of Apolipoproteins Al (121 mg/dL) and A2 (37.6 mg/dL) were
essentially identical to control values (p = 0.44 and p = 0.64, respe
ctively). The differences in these biochemical markers between the two
groups could not be explained by differences in postmortem interval o
r by the presence of recently ingested food. These findings indicate t
hat elevations of plasma cholesterol, triglycerides, LDL, and Apolipop
rotein B are important biochemical markers for the development of earl
y and apparently clinically silent yet life-threatening coronary arter
y disease.